US Patent Issued to REPRIEVE CARDIOVASCULAR on Nov. 18 for "Fluid therapy based on adjusted urine output rate, and associated systems, devices, and methods" (California, Connecticut, Massachusetts Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,471,842, issued on Nov. 18, was assigned to REPRIEVE CARDIOVASCULAR INC. (Milford, Mass.).

"Fluid therapy based on adjusted urine output rate, and associated systems, devices, and methods" was invented by Andrew V. Halpert (Brookline, Mass.), Antony Jonathan Fields (San Francisco) and Jeffrey Testani (New Haven, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This present disclosure relates to fluid therapy based on adjusted urine output rate and/or sodium output rate, and associated systems, devices, and methods. Exemplary methods can include receiving a sodium excretion input for the patient; receiving a urine output rate; determining an adjusted...